Skip to main content
KYTX
NASDAQ Life Sciences

Kyverna Extends $15M Loan Draw Window, Securing Future Capital Access

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$9.82
Mkt Cap
$602.481M
52W Low
$2.52
52W High
$13.67
52W Position info
290% above low
Off High info
28% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

KYTX has more than doubled off its 52-week low of $2.52.

Summary

Kyverna Therapeutics amended its $150 million term loan facility with Oxford Finance, extending the draw period for the remaining $15 million of Term A loans until December 31, 2026. This provides the company with crucial financial flexibility and continued access to capital, supporting its ongoing clinical development and regulatory efforts, including the miv-cel BLA submission. The amendment also extends the availability of future tranches if the initial $15 million is fully utilized, though it includes an upfront fee and a non-utilization fee.

At the time of this announcement, KYTX was trading at $9.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $602.5M. The 52-week trading range was $2.52 to $13.67. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

KYTX - Latest Insights

KYTX
Nov 12, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.20
Real-time Price: $4.89 info
Change: -$0.3054 (-6%) info
Market Cap: $276.28M info
KYTX
Nov 12, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.20
Real-time Price: $4.89 info
Change: -$0.3054 (-6%) info
Market Cap: $276.28M info
KYTX
Oct 23, 2026, 10:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.43
Real-time Price: $4.89 info
Change: -$0.5354 (-10%) info
Market Cap: $276.28M info
KYTX
Sep 24, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $7.05
Real-time Price: $4.89 info
Change: -$2.16 (-31%) info
Market Cap: $276.28M info
KYTX
Sep 24, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $7.19
Real-time Price: $4.89 info
Change: -$2.30 (-32%) info
Market Cap: $276.28M info